Sight DiagnosticsⓇ is a blood diagnostic company that combines machine vision and AI to improve health through fast, convenient and accurate diagnostics. Developed over almost a decade of research, Sights technology combines the latest innovations in blood sample preparation, optics, chemistry, biology, physics and computer science.
Sights first product, ParasightTM, has diagnosed malaria in nearly 1 million tests across 24 countries. Sight OLOⓇ, Sights latest blood analyzer, digitizes blood with only 2 drops of a finger prick or venous sample and provides lab-grade CBC results in minutes at the point of care. Sight has growing offices in the UK, the US and Israel.